Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : AffinityAI
Deal Size : Undisclosed
Deal Type : Collaboration
LenioBio Partners with AffinityAI to Accelerate Discovery of Novel Complex Proteins
Details : The collaboration combines LenioBio's proprietary cell-free protein expression platform, ALiCE, with AffinityAI's advanced design engine, Designerbodies, to accelerate the discovery of novo proteins.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
September 03, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : AffinityAI
Deal Size : Undisclosed
Deal Type : Collaboration